Elutia Inc. (ELUT) SEC Filings — 2025
17 SEC filings for Elutia Inc. (ELUT) in 2025.
Filings
- Elutia's Q3 Net Loss Widens Amidst Sales Dip, Warrant Gains Cushion Nine-Month Results — 10-Q · Nov 12, 2025
- Elutia Inc. 8-K Filing — 8-K · Nov 6, 2025
- Elutia Inc. Appoints New Chief Medical Officer — 8-K · Oct 14, 2025
- Elutia Inc. Completes Acquisition of Azura Life Sciences — 8-K · Oct 7, 2025
- Elutia Inc. Files 8-K for Material Agreement — 8-K · Sep 9, 2025
- Elutia Inc. Enters Loan Agreement — 8-K · Aug 20, 2025
- Elutia Inc. Files 8-K on Financials — 8-K · Aug 14, 2025
- Elutia Narrows Q2 Loss Amidst Litigation Costs, Sales Dip — 10-Q · Aug 14, 2025
- Elutia Inc. Files 8-K on Shareholder Votes — 8-K · Jun 4, 2025
- Elutia Inc. Q1 2025 10-Q: Assets and Liabilities Detailed — 10-Q · May 13, 2025
- Elutia Inc. Files 8-K on Agreements and Operations — 8-K · May 8, 2025
- Elutia Inc. Terminates Material Definitive Agreement — 8-K · May 6, 2025
- Elutia Inc. Files Definitive Proxy Statement — DEF 14A · Apr 4, 2025
- Elutia Inc. Files 2024 Annual Report — 10-K · Mar 11, 2025
- Elutia Inc. Relocates Principal Executive Offices — 8-K · Mar 6, 2025
- Elutia Inc. Files 8-K with Material Agreement Details — 8-K · Feb 4, 2025
- Elutia Inc. Files 8-K, Formerly Aziyo Biologics — 8-K · Feb 3, 2025